Small biotech Target a very small, specialized customer base in biotechnology research. Zenobia Fragments operates with a lean team (2-10 employees) and revenue under $1M, suggesting decision-making is agile but budget-constrained. Sales opportunities should emphasize affordable, modular product bundles and clear ROI tied to accelerating Zenobia Therapeutics’ research.

Academic collaboration Position products as enablers for accelerating in-house research and enabling faster discovery. Highlight how offerings complement Zenobia Therapeutics’ work and can reduce time-to-result, making them attractive to research-minded buyers who value reliability and speed.

External visibility Leverage digital channels the company already uses (Google Analytics, YouTube, RSS, Wix) to tailor outreach. Propose educational content, product demos, and case studies that demonstrate concrete applications and outcomes to build credibility with prospective buyers.

Funding sensitivity With revenue under $1M, procurement may favor low-risk, cost-efficient solutions and flexible purchasing options. Propose smaller SKU options, pilot programs, and volume-based discounts to align with budgeting realities and encourage initial adoption.

Strategic fit Directly connect to Zenobia Fragments’ mission of advancing research and discovering new treatments. Frame offerings as essential tools for expanding their internal capabilities, potentially creating opportunities for co-development or exclusive sourcing agreements that deepen supplier relationships.